ストックスクリーナーアプリを入手
0.6311
4.34%
-0.0274
前日終値:
$0.6585
開ける：
$0.637
24時間の取引高:
869.00K
Relative Volume:
0.12
時価総額：
$17.44M
収益：
$5.75M
当期純損益:
$-38.96M
株価収益率:
-0.0506
EPS:
-12.47
ネットキャッシュフロー:
$-32.63M
1週間 パフォーマンス:
+13.31%
1か月 パフォーマンス:
-30.01%
6か月 パフォーマンス:
-88.07%
1年 パフォーマンス:
-91.81%
1日の値動き範囲:
$0.6121
$0.655
1週間の範囲:
$0.5595
$0.7373
52週間の値動き範囲:
$0.51
$20.60
Kala Bio Inc Stock (KALA) Company Profile
KALA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
KALA
Kala Bio Inc
|
0.6262 | 18.34M | 5.75M | -38.96M | -32.63M | -12.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.73 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
799.51 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
425.17 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
813.10 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.43 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Kala Bio Inc Stock (KALA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-30 | ダウングレード | Mizuho | Outperform → Neutral |
| 2025-09-29 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2025-09-29 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2025-09-08 | 開始されました | Mizuho | Outperform |
| 2025-07-11 | 開始されました | Ladenburg Thalmann | Buy |
| 2022-03-30 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2021-08-06 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-09-14 | ダウングレード | Jefferies | Buy → Hold |
| 2020-07-23 | 開始されました | Northland Capital | Outperform |
| 2020-06-01 | 再開されました | Oppenheimer | Outperform |
| 2020-05-27 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-03-09 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-12-17 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2019-03-14 | 開始されました | Jefferies | Buy |
すべてを表示
Kala Bio Inc (KALA) 最新ニュース
KALA BIO eliminates debt overhang through equity settlements - TipRanks
KALA BIO Signs Multiple Material Agreements - TradingView — Track All Markets
KALA BIO Clears Oxford DebtA Fresh Start Ahead? - Nasdaq
Kala Bio Settles $10.6 Million Debt; Shares Rise After-Hours - marketscreener.com
Kala Bio settles $10.6 million debt with Oxford Finance By Investing.com - Investing.com Nigeria
Kala Bio settles $10.6 million debt with Oxford Finance - Investing.com India
Kala Bio Settles Approximately $10.6 Million Of Debt - TradingView — Track All Markets
KALA BIO Settles Approximately $10.6 million of Debt - The Manila Times
Kala Bio fully settles loan, strengthens balance sheet - MSN
KALA BIO Inc. (KALA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Kala Bio Inc pays $2 million to Oxford Finance LLC as part of settlement agreement - marketscreener.com
KALA BIO Announces Conditional Resignations of Six Directors - TradingView — Track All Markets
Top Penny Stocks To ResearchDecember 4th - MarketBeat
Why Did Indaptus Therapeutics Surge 64% In After-Hours Trading? - Benzinga
Support Test: What insider trading reveals about AAOI stockJuly 2025 Sentiment & High Return Trade Guides - moha.gov.vn
Market Review: How KALA BIO Inc. stock trades before earnings2025 Winners & Losers & Short-Term Swing Trade Alerts - Улправда
Will KALA BIO Inc. stock see PE expansion2025 Growth vs Value & High Win Rate Trade Tips - Улправда
How KALA BIO Inc. stock reacts to bond yieldsJuly 2025 Big Picture & Precise Buy Zone Identification - DonanımHaber
Can KALA BIO Inc. stock deliver sustainable ROEMarket Weekly Review & Growth Focused Stock Reports - DonanımHaber
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Risk Check: Will KALA BIO Inc. stock see PE expansionRisk Management & Fast Exit and Entry Trade Guides - Улправда
How KALA BIO Inc. stock trades before earningsWeekly Market Report & Consistent Income Trade Recommendations - ulpravda.ru
Kala Bio Stock Slides 42% With A 8-Day Losing Spree - Trefis
KALA BIO Announces New CEO and Funding Deal - The Globe and Mail
Oxford Finance Llc Net Worth (2025) - GuruFocus
Kala Bio dismisses Deloitte as auditor, no successor named By Investing.com - Investing.com Canada
KALA BIO announces new CEO and funding deal - MSN
Kala Bio dismisses Deloitte as auditor, no successor named - Investing.com
Kala Bio (NASDAQ: KALA) details dismissal of Deloitte as auditor - Stock Titan
Kala Bio sets annual meeting for January 30, 2026 and updates on investment agreements By Investing.com - Investing.com Nigeria
KALA BIO (Nasdaq: KALA) details Lazar financing shift and 2026 meeting - Stock Titan
Can Sobha Limited Maintain Its Share of Global Market for Its ProductUtilities Sector Analysis & Affordable Portfolio Trading - earlytimes.in
Why Did KALA BIO Shares Jump Over 22% After Hours? - Sahm
What drives KALA BIO Inc stock priceSmall Cap Stock Opportunities & Low Risk Wealth Plans - earlytimes.in
You might want to take a look at Kala Bio Inc (KALA) now - setenews.com
Kala Bio Shares Jump After $6 Million Funding Deal With Investor David Lazar - MSN
Kala Bio enters securities purchase agreement with David Lazar, names him CEO - MSN
KALA BIO closes $10 million registered direct offering - Investing.com India
KALA BIO Raises $10M in Direct Offering - TipRanks
KALA BIO Raises $10 Million From Direct Offering - marketscreener.com
KALA BIO closes $10 million registered direct offering By Investing.com - Investing.com South Africa
KALA BIO Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules - The Manila Times
KALA BIO (NASDAQ: KALA) completes $10 million offering of 10,000,000 shares to repay debt - Stock Titan
Will KALA BIO Inc. stock continue upward momentumMarket Risk Summary & Community Consensus Picks - Newser
Kala Bio raises $10 million in registered direct offering By Investing.com - Investing.com Nigeria
KALA BIO Stock (NASDAQ: KALA): New $10 Million Offering, Debt Deal and Delisting Risk – December 4, 2025 Update - ts2.tech
KALA BIO, Inc. (KALA) Stock: Surges 21.62% Amid Exciting New Offering Announcement - parameter.io
KALA Bio (KALA) Announces $10 Million Direct Stock Offering - GuruFocus
Kala Bio Inc (KALA) 財務データ
収益
当期純利益
現金流量
EPS
Kala Bio Inc (KALA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Reumuth Mary | CHIEF FINANCIAL OFFICER |
Oct 22 '25 |
Sale |
0.83 |
32,230 |
26,751 |
29,873 |
| Reumuth Mary | CHIEF FINANCIAL OFFICER |
Oct 23 '25 |
Sale |
0.82 |
967 |
793 |
28,906 |
| Bazemore Todd | Director |
Oct 22 '25 |
Sale |
0.83 |
47,768 |
39,647 |
35,932 |
| Brazzell Romulus K | SEE REMARKS |
Oct 22 '25 |
Sale |
0.83 |
46,748 |
38,801 |
35,952 |
| Kharabi Darius | CHIEF BUSINESS OFFICER |
Oct 22 '25 |
Sale |
0.83 |
20,806 |
17,269 |
41,760 |
0.90%
大文字化:
|
ボリューム (24 時間):